Helium Leak Detection and Its Applications Throughout the Pharmaceutical Product Lifecycle

Helium mass spectrometry (HeMS) leak detection is an important method for ensuring pharmaceutical container closure integrity. It is particularly valuable for sensitive drug products, for which any packaging defect may lead to contamination, degradation of the formulation, or loss of efficacy. By leveraging the properties of helium, this technology can identify minute leaks in pharmaceutical containers and help protect product stability, safety, and quality.

 

1. How Helium Leak Detection Works

 

Helium leak detection works by introducing helium into a sealed system, such as a pharmaceutical package, and using a mass spectrometer to detect whether helium escapes. The process generally involves the following steps:

 

01. Helium Introduction

A controlled amount of helium is introduced into the sealed system. Helium is used because of its small atomic size, chemical inertness, and ability to pass through very small leaks in packaging materials.

 

02. Vacuum and Detection

The system is placed under vacuum, and the mass spectrometer detects and quantifies helium escaping from the system. The instrument identifies helium by its characteristic mass-to-charge ratio (m/z), distinguishing it from other gases.

 

03. Leak Detection

The amount of detected helium correlates with the leak rate. A mass spectrometer may detect leak rates as low as 10⁻¹⁰ mbar·L/s, demonstrating the high sensitivity of the technique.

 

04. Quantification and Localization

Advanced systems can not only measure leak rates precisely but also locate the leak within a package or system, supporting targeted troubleshooting and failure analysis.

 

2. Key Characteristics and Advantages of HeMS Leak Detection

 

Key Characteristics

• High sensitivity: Helium's small atomic size enables highly sensitive detection of very small leaks, supporting container closure integrity assessment.
• Chemical inertness: Helium is chemically inert and does not readily react with drug products or packaging materials.
• Fast and accurate: Results can often be obtained within minutes, making the method useful in development and high-throughput manufacturing environments.
• Quantitative measurement: Leak rates can be quantified to provide information about the magnitude of a leak.

 

Advantages

• Early detection: Very small leaks can be identified before they lead to contamination or product degradation.
• Broad applicability: The method can be used with various rigid and flexible packaging formats and materials, including glass, plastic, and flexible bags.
• Support for regulatory compliance: When appropriately validated and applied, HeMS data can support efforts to meet applicable quality and regulatory requirements, including those relevant to FDA, EMA, and NMPA expectations.
• Product stability: Identifying package leaks can help prevent the ingress of moisture, oxygen, and contaminants, which may affect product stability and shelf life.
• Potential for non-destructive testing: Depending on the test configuration, leak testing can be performed without damaging the product or package.

 

3. Applications During Packaging Development

 

During packaging development, the main objective is to design a packaging solution that protects the drug product from external factors such as air, moisture, and microorganisms while maintaining product stability. HeMS can be used in the following areas:

 

01. Early-Stage Packaging Development

HeMS can be used to assess leakage in preliminary packaging designs and materials, helping identify potential issues before the final design enters production.

 

02. Verification of Packaging Component Compatibility

HeMS can help assess the effectiveness of the interfaces between the sealing components of a packaging system and evaluate its sealing performance. This is particularly important for drug products that are sensitive to environmental conditions. In line with the Quality by Design (QbD) approach, poor compatibility among packaging components may result in an unsuitable package even when subsequent manufacturing processes are well controlled. The source article refers to USP General Chapter <382> as requiring packaging component compatibility studies to demonstrate compliance with the product's maximum allowable leakage limit (MALL); this regulatory statement should be verified against the current official USP text before publication.

 

03. Material Selection

HeMS can help evaluate helium permeation through different materials, such as plastics, aluminum, and glass, supporting the selection of suitable materials with appropriate barrier properties for pharmaceutical packaging.

 

04. Verification of Innovative Packaging

HeMS can support leak testing of innovative packaging technologies, such as child-resistant closures and ophthalmic bottles with antimicrobial filters, as well as newer packaging materials such as COC/COP vials, to assess whether the required quality and integrity are maintained.

 

4. Applications During Process Validation

 

During process validation, HeMS can help assess whether manufacturing processes consistently produce pharmaceutical products that meet established quality requirements. This includes detecting package leaks that could affect product quality. Key applications include:

 

01. Crimping Process Validation and Optimization

HeMS can be used to evaluate vial crimping and assess whether the vial closure provides adequate sealing. Defects in the crimping process may lead to contamination, reduced product quality, or loss of efficacy. HeMS can also support process optimization by helping evaluate parameters such as crimping force and clearance, with the aim of improving the consistency and stability of subsequently produced units.

 

02. Batch Process Verification

Periodic leak testing during process validation can help verify that packaging from each batch meets the specified sealing requirements and that package integrity is maintained during scale-up and routine production.

 

03. Support for Regulatory Submissions

Process validation results may form part of the validation documentation submitted to regulatory authorities to demonstrate that the process meets applicable Good Manufacturing Practice (GMP) requirements.

 

04. Leak Localization

When a process fails, helium sniffing and helium spray methods can help identify leak locations and investigate potential causes, supporting process improvement and optimization.

 

5. Applications During Commercial Manufacturing

During commercial manufacturing, helium leak detection can help assess the integrity of packaging produced at scale. HeMS can play a role in the following areas:

 

01. Routine Leak Testing

HeMS can be used for routine leak testing in commercial manufacturing. For packages filled or pressurized with helium as part of the process, 100% in-line inspection may be feasible. For packages that do not use helium filling, sampling-based inspection may be considered, depending on the process and test design. Compared with other container closure integrity testing (CCIT) methods, such as vacuum decay and pressure decay, helium mass spectrometry can offer higher sensitivity in suitable applications, particularly for large-volume packaging systems such as single-use system (SUS) bioreactor bags. Method selection and comparative performance should be established for the specific package and test configuration.

 

02. Batch-to-Batch Consistency

HeMS testing can contribute to monitoring packaging quality across production batches and supporting applicable quality-control requirements.

 

03. Minimizing Downtime

Rapid leak testing can help identify defects promptly and support timely investigation while minimizing disruption to manufacturing schedules.

 

04. Product Integrity

Identifying package defects can help reduce contamination risks and support product stability throughout its shelf life.

 

6. Applications During Stability Studies

 

Stability studies evaluate a drug product's ability to maintain its potency, quality, and safety during storage. HeMS can support these studies in several ways:

 

01. Assessing Container Closure Integrity

During stability studies, HeMS can help assess whether packaging integrity is maintained and whether the package continues to protect the drug product from environmental factors such as temperature, humidity, and light.

 

02. Accelerated and Real-Time Stability Studies

HeMS can be used to assess packaging integrity under accelerated stability conditions, such as elevated temperature and humidity, and during real-time storage, helping identify potential package failure points.

 

03. Supporting Shelf-Life Assessment

Leak testing can provide evidence about whether package integrity is maintained over the intended shelf life, helping assess the risk of product degradation or contamination.

 

04. Regulatory Documentation

Stability study results, including leak-test data where relevant, may contribute to regulatory submissions and help support the proposed long-term stability of a drug product.

 

7. Applications in Cryogenic CCIT Studies

 

Maintaining container closure integrity under cryogenic conditions is particularly important for certain biologics and vaccines that may require storage at temperatures as low as −80°C. HeMS can be used in cryogenic container closure integrity testing (CCIT) to evaluate whether packaging continues to provide adequate protection under extreme conditions. Key applications include:

 

01. Cold-Chain Packaging Verification

For products requiring cryogenic storage and transportation, including certain biologics, mRNA vaccines, and cell and gene therapy (CGT) products, HeMS can help assess sealing performance at very low temperatures. It can also support evaluation of the compatibility of closure components, such as vials, stoppers, and aluminum caps, during low-temperature storage.

 

02. Low-Temperature Performance Studies for Packaging Manufacturers

HeMS can be used to evaluate the low-temperature resistance and stability of packaging materials and packaging systems, supporting assessment of their suitability for cryogenic storage and transportation of biologics and for required freeze–thaw conditions.

 

03. Regulatory Considerations

The source article notes that regulators may expect evidence that packaging for cryogenically stored drug products maintains integrity throughout distribution and storage. It also describes cases in which the absence of cryogenic CCIT studies has been challenged during CDE reviews or GMP inspections. HeMS may provide supporting data for such assessments. Specific regulatory expectations should be confirmed for the product, jurisdiction, and current guidance.

 

Conclusion

Helium leak detection is a valuable tool that can be applied throughout the pharmaceutical product lifecycle. From packaging development and process validation to commercial manufacturing, stability studies, and cryogenic CCIT, helium-based testing can support container closure integrity assessment and pharmaceutical product quality. It can contribute to quality assurance, regulatory documentation, and the maintenance of product stability from manufacturing through delivery to patients.